Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe

Tissue Antigens

Volumn 71, Issue 3, 2008, Pages 213-218

  Hernandez Charro B ^a   Donat, E ^b   Miner, I ^c   Aranburu, E ^d   Sanchez Valverde F ^a   Ramos Arroyo, M A ^a  

^a Universidad Pública de Navarra   (Spain)

^b HOSPITAL INFANTIL LA FE   (Spain)

^c Hospital Nuestra Senora de Aranzazu   (Spain)

^d Blood Bank of Navarra   (Spain)

Author keywords

Celiac disease; Gene dosage; Human leukocyte antigen haplotypes; Risk susceptibility

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CASE CONTROL STUDY; CELIAC DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EUROPE; GENE FREQUENCY; GENETIC RISK; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CELIAC DISEASE; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENETIC COMPLEMENTATION TEST; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; MALE; RISK FACTORS; SPAIN;

EID: 38949149289     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.01003.x     Document Type: Article

References (24)

1. Catassi C, Fabiani E, Ratdch IM et al. The celiac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 1996 : 412 : 29 35.
2. Bingley PJ, Williams AJ, Norcross AJ et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 2004 : 328 : 322 3.
3. van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 2005 : 19 : 323 39.
4. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ (alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993 : 41 : 173 7.
5. Mearin ML, Biemond I, Pena AS et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 1983 : 24 : 532 7.
6. Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 1992 : 40 : 90 7.
7. Meddeb-Garnaoui A, Zeliszewski D, Mougenot JF et al. Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French population. Hum Immunol 1995 : 43 : 190 9.
8. Congia M, Cucca F, Frau F et al. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol 1994 : 40 : 138 142.
9. van Belzen MJ, Koeleman BP, Crusius JB et al. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun 2004 : 5 : 215 220.
10. Margaritte-Jeannin P, Babron MC, Bourgey M et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 2004 : 63 : 562 7.
11. Clerget-Darpoux F, Bouguerra F, Kastally R et al. High risk genotypes for celiac disease. C R Acad Sci III 1994 : 317 : 931 6.
12. Ploski R, Ascher H, Sollid LM. HLA genotypes and the increased incidence of coeliac disease in Sweden. Scand J Gastroenterol 1996 : 31 : 1092 7.
13. Karell K, Holopainen P, Mustalahti K, Collin P, Maki M, Partanen J. Not all HLA DR3 DQ2 haplotypes confer equal susceptibility to coeliac disease: transmission analysis in families. Scand J Gastroenterol 2002 : 37 : 56 61.
14. Louka AS, Nilsson S, Olsson M et al. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 2002 : 60 : 147 154.
15. Ramos-Arroyo MA, Feijoo E, Sanchez-Valverde F et al. Heat-shock protein 70-1 and HLA class II gene polymorphisms associated with celiac disease susceptibility in Navarra (Spain). Hum Immunol 2001 : 62 : 821 825.
16. Walker-Smith. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990 : 65 : 909 11.
17. Sollid LM, Thorsby E. The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 1990 : 36 : 136 7.
18. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993 : 105 : 910 922.
19. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003 : 61 : 105 17.
20. Lundin KE, Sollid LM, Qvigstad E et al. T lymphocyte recognition of a celiac disease associated cis or trans encoded HLA-DQ alpha/beta-heterodimer. J Immunol 1990 : 145 : 136 9.
21. Lundin KE, Scott H, Hansen T et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993 : 178 : 187 96.
22. Vader W, Stepniak D, Kooy Y et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A 2003 : 100 : 12390 12395.
23. Tollefsen S, Arentz-Hansen H, Fleckenstein B et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006 : 116 : 2226 36.
24. Karell K, Louka AS, Moodie SJ et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003 : 64 : 469 477.